“Tapinarof Cream 1% Once Daily: Disease Control Off Treatment and Minimal Disease Activity Through End of Remittive Period in a 1-year Trial”, J of Skin, vol. 7, no. 2, p. s125, Mar. 2023, doi: 10.25251/skin.7.supp.125.